Articles with Puma Biotechnology
Puma Biotechnology
Puma Bio (PBYI) Restricting Access to Breast Cancer Event at ASCO 2015 - TheStreet
Puma Biotechnology Presents Outcomes from the Metastatic Breast Cancer Cohort of the SUMMIT Trial at the ASCO 2022 Annual Meeting
Puma's BioEvolution Project Introduces A Shoe That Adapts To The Body – FashNerd
Puma Biotech Plunges on Sharp Drop in Cancer-Drug Sales - TheStreet
Puma Biotechnology up 15% after quarterly earnings beats (NASDAQ:PBYI) | Seeking Alpha
Former Puma Biotech executive gets U.S. prison term for insider trading | Reuters.com
PumaBiotech (@pumabiotech) / Twitter
Puma Biotechnology Inc (PBYI) Stock 10 Year History
Puma Biotechnology
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | citybiz
Puma Bio Drive Golf Shoes Mens CLOSEOUT New 187581- Black or Silver- Choose Size - Walmart.com
Puma Biotechnology - Crunchbase Company Profile & Funding
Puma Biotechnology
Puma Biotechnology Reports Results of PB272 (neratinib) in P-III NALA Trial for Patients with 2L+ HER2+ Metastatic Breast Cancer #ASCO2019
Puma Bio: Now Or Never. I Go With Never (NASDAQ:PBYI) | Seeking Alpha
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma Bio Stock: Still Worthy After Earnings Surprise (NASDAQ:PBYI) | Seeking Alpha
Puma Bio: Recent Sell-Off Brings My Position Out Of Mothball (NASDAQ:PBYI) | Seeking Alpha
Puma Bio: Sifting Through The Q4 Earnings Report (NASDAQ:PBYI) | Seeking Alpha
Puma Bio: Now Or Never. I Go With Never (NASDAQ:PBYI) | Seeking Alpha
